Skip to main content

Advertisement

Log in

Eradication of convalescent-phaseSalmonella carriage in children with two oral doses of pefloxacin

  • Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Fifteen children (age range 1.5 months to 7.2 years), who were excluded from schools or nurseries due to asymptomatic convalescent-phase non-typhoidalSalmonella carriage, received two oral doses of pefloxacin (12 mg/kg on days 1 and 4) and were examined on days 10, 30, 45 and 60. Definitive eradication was observed in 13 patients, all of whom had initial lowSalmonella counts in stools and were culture-negative by day 10. In the two patients who failed to respond, the same treatment was effective when repeated 4 and 6 months later respectively. No side-effects were observed. In six other children, considered as controls, eradication by day 10 was observed in only one case after administration of amoxicillin for eight days. Two oral doses of pefloxacin could be a useful and safe means for eleminatingSalmonella carriage in young children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dixon JMS Effect of antibiotic treatment on duration of excretion ofSalmonella typhimurium by children. British Medical Journal 1965, ii: 1343–1345.

    Google Scholar 

  2. Asperilla MO, Smego RA, Keith Scott L Quinolone antibiotics in the treatment of salmonella infections. Reviews of Infectious Diseases 1990, 12: 873–889.

    PubMed  Google Scholar 

  3. Buchwald DS, Blaser MJ A review of human salmonellosis. II: Duration of excretion following infection with non-typhiSalmonella Reviews of Infectious Diseases 1984, 6: 345–356.

    Google Scholar 

  4. American Academy of Pediatrics Reports of the Committee on Infectious Diseases. Volume 1, 1991, p. 418–423.

    Google Scholar 

  5. Gendrel D, Raymond J, Legall MA, Bergeret M, Badoual J Use of pefloxacin after failure of initial antibiotic treatment in children with severe salmonellosis. European Journal of Clinical Microbiology & Infectious Diseases 1993, 12: 209–211.

    Google Scholar 

  6. Pecquet S, Ravoire S, Andremont A Faecal excretion of ciprofloxacin after a single oral dose and its effect on faecal bacteria in healthy volunteers. Journal of Antimicrobial Chemotherapy 1990, 26: 125–129.

    PubMed  Google Scholar 

  7. Schaad UB, Stoupis C, Wegwood J, Tschaeppeler H, Vock P Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a 3-month course of ciprofloxacin. Pediatric Infectious Disease Journal 1991, 10: 723–729.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raymond, J., Moulin, F., Badoual, J. et al. Eradication of convalescent-phaseSalmonella carriage in children with two oral doses of pefloxacin. Eur. J. Clin. Microbiol. Infect. Dis. 13, 307–310 (1994). https://doi.org/10.1007/BF01974606

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01974606

Keywords

Navigation